You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Agarwal Arjun · SEC Form 4 · Filed Jun 15, 2026
Sale
Calculated transaction value
$229.31K
Agarwal Arjun Senior Vice President, Finance
ORKA
Oruka Therapeutics
ORKA
Transaction date
Jun 12, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 3 days later
ORKA daily price context
Close on/before transaction
$69.89
Jun 12, 2026
First close after public filing
$67.71
Jun 16, 2026
30-day return after filing
+27.97%
Through Jul 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,260 shares @ $70.34
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000064
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$837.21K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 15, 2026 | $27.53K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $50.18K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $127.05K |
| Oruka Therapeutics, Inc. ORKA | Sale | Jun 12, 2026 | $303.15K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Jun 12, 2026 | $229.31K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $100K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Jun 12, 2026 | $0 |